Beneficial actions of citrus polymethoxy flavonoids in treating acne

Clinical Dermatology: Retinoids and other Treatments

Volumn 24, Issue 2, 2008, Pages 22-27

  Sato, Takashi ^a   Ito, Akira ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51249114714     PISSN: 1750306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Pawin H, Beylot C, Chivot M et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol, 2004, 14, 4-12.
2. Krautheim A, Gollnick HP. Acne: topical treatment. Clin Dermatol, 2004, 22, 398-407.
3. Chivot M. Retinoid therapy for acne. Am J Clin Dermatol, 2005, 6, 13-19.
4. Layton AM. A review on the treatment of acne vulgaris. Int J Clin Pract, 2006, 60, 64-72.
5. Seki T, Morohashi M. Effect of some alkaloids, flavonoids and triterpenoids, contents of Japanese-Chinese traditional herbal medicines, on the lipogenesis of sebaceous glands. Skin Pharmacol, 1993, 6, 56-60.
6. Akamatsu H, Asada Y, Horio T. Effect of keigai-rengyo-to, a Japanese kampo medicine, on neutrophil functions: a possible mechanism of action of keigai-rengyo-to in acne. J Int Med Res, 1997, 25, 255-265.
7. Lin N, Sato T, Ito A. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook, f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Arthritis Rheum, 2001, 44, 2193-2200.
8. Pinn G. Herbal medicine in infectious disease. Aust Fam Physician, 2001, 30, 681-684.
9. Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol Ther, 2003, 16, 106-113.
10. Higaki S, Nakamura M, Morohashi M et al. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigairengyo-to. Int J Dermatol, 2004, 43, 103-107.
11. Murakami A, Nakamura Y, Torikai K et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res, 2000. 60, 5059-5066.
12. Chi YS. Lim H. Park H et al. Effects of wogonin. a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol, 2003, 66, 1271-1278.
13. Stahl W. Sies H. Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol Biotechnol. 2007, 37, 26-30.
14. Ishiwa J. Sato T, Mimaki Y et al. Citrus flavonoid, nobiletin, suppresses the production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J Rheumatol. 2000, 27, 20-25.
15. Minagawa A, Otani Y, Kubota T et al. The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Jpn J Cancer Res. 2001, 92, 1322-1328.
16. Sato T, Koike L. Miyata Y et al. Inhibition of activated protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin. a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinase 1 and 9 in human fibrosarcoma HT-1080 cells. Cancer Res, 2002, 62, 1025-1029.
17. Lin N. Sato T, Takayama Y et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol, 2003, 65, 2065-2071.
18. 2-terminaI kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin, Mol Cancer Ther. 2004, 3, 839-847.
19. Tanaka S, Sato T, Akimoto N et al. Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro. Biochem Pharmacol, 2004, 68, 33-439.
20. Yoshimizu N. Otani Y. Saikawa Y et al. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther. 2004, 20, 95-101.
21. Miyata Y, Sato T, Imada K et al. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun, 2008, 366, 168-173.
22. Sato T, Takahashi A, Kojima M et al. A citrus polymethoxy flavonoid, nobiletin inhibits sebum production and sebocyte proliferation, and augments sebum excretion in hamsters. J Invest Dermatol. 2007, 127, 2740-2748.
23. Bialecka A, Mak M, Biedron R et al. (2005) Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis. implications for chronic inflammatory acne. Arch Immunol Ther Exp, 2005, 53, 79-85.
24. Rosenfield RL, Deplewski D, Kentsis A et al. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol. 1999, 112, 226-232.
25. 2 production. J Invest Dermatol, 2005, 125, 865-872.
26. 2 are active in sebaceous glands. J Mol Med, 2006, 84, 75-87.
27. Smith TM, Cong Z, Gilliland KL et al. Insulin-like growth factor-1 induces lipid production in human SEB-I sebocytes via sterol response element-binding protein-1. J Invest Dermatol, 2006, 126, 1226-1232.
28. Trivedi NR, Cong Z, Nelson AM et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol. 2006, 126, 2002-2009.
29. Bojar RA, Holland KT. Acne and Propionibacterium acnes. Clin Dermatol. 2004, 22, 357-379.
30. κB activation in human monocytes. J Dermatol Sci. 2002, 29, 97-103.
31. Graham GM, Farrar MD, Cruise-Sawyer JE et al. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol. 2004, 150, 421-428.
32. Kim J. Review of the innate immune response in acne vulgaris: Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005, 211, 193-198.
33. Choi JY, Piao MS, Lee JB et al. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-α in human dermal fibroblasts. J Invest Dermatol. 2008, 128, 846-854.
34. Boni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003, 4, 273-276.
35. Triantafilou M. Triantafilou K. The dynamics of LPS recognition: complex orchestration of multiple receptors. J Endotoxin Res. 2005, 11, 5-11.
36. Robak J, Gryglewski RJ. Flavonoids are scavengers of Superoxide anions. Biochem Pharmacol. 1988, 37, 837-841.
37. Kawaii S, Tomono Y, Katase E et al. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biolechnol Biochem. 1999, 63, 896-899.
38. Casaschi A, Wang Q, Dang K et al. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase. Lipids. 2002, 37, 647-652.
39. Cha JY, Cho YS. Kim I et al. Effect of hesperetin, a citrus flavonoid, on the liver triacylglycerol content and phosphatidate phosphohydrolase activity in orotic acid-fed rats. Plant Foods Hum Nutr. 2001, 56, 349-358.
40. Zouboulis CC, Korge B, Akamatsu H et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol, 1991, 96, 792-79.
41. Kim MJ, Ciletti N, Michel S et al. The role of specific retinoid receptors in sebocyte growth and differentiation in culture. J Invest Dermatol, 2000, 114, 349-353.
42. 3 suppress lipogenesis in hamster sebaceous gland cells in vitro. J Invest Dermatol. 2001, 117, 965-970.
43. Nelson AM, Gilliland KL, Cong Z et al. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-I sebocytes. J Invest Dermatol, 2006, 126, 2178-2189.
44. Wróbel A, Seitmann H, Fimmel S et al. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol. 2003, 120, 175-181.
45. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006, 54, 258-265.
46. Eady EA, Gloor M. Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology, 2003, 206 54-56.
47. Ross JI, Snelling AM. Carnegie E et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003, 148, 467-478.
48. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents, 2005, 26, 343-356.
49. Nakagawa H, Takaishi Y, Tanaka N et al. Chemical constituents from the peels of Citrus sudachi. J Nat Prod, 2006, 69, 1177-1179.
50. Lim YH, Kim IH, Seo JJ. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. J Microbiol, 2007, 45, 473-477.
51. Johann S, Lopes de Oliveira V. Pizzolatti MG et al. Antimicrobial activity of wax and hexane extracts from Citrus spp. peels. Mem Inst Oswaldo Cruz, 2007, 102, 681-685.
52. Lee WL, Shalita AR. Suntharalingam K et al. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun, 1982, 35, 71-78.
53. Kawaii S, Tomono Y, Katase E et al. Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res, 1999, 19, 1261-1269.
54. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr, 2002, 22, 19-34.
55. Ravindranath MH, Muthugounder S, Presser N et al. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol, 2004, 546, 121-165.
56. Nagase H, Yamakuni T, Matsuzaki K et al. Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry, 2005, 44, 13683-13691.
57. Kuppusamy UR, Das NP. Potentiation of β-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochem Pharmacol, 1994, 47, 521-529.
58. Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol, 2001, 280, C807-813.
59. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology, 1998, 196, 130-134.
60. Nagai A, Sato T, Akimoto N et al. Isolation and identification of histone H3 protein enriched in microvesicles secreted from cultured sebocytes. Endocrinology, 2005, 146, 2593-2601.
61. Parseghian MH, Luhrs KA. Beyond the walls of the nucleus: the role of histones in cellular signaling and innate immunity. Biochem Cell Biol, 2006, 84, 589-604.